Skip to main content
Clinical Trials/NCT07415993
NCT07415993
Completed
Not Applicable

A Prospective Randomized Trial Comparing the Effects of Anti-reflux Versus Standard Ureteral Stents on Male Sexual Function

Rong Wang1 site in 1 country96 target enrollmentStarted: June 30, 2020Last updated:

Overview

Phase
Not Applicable
Status
Completed
Sponsor
Rong Wang
Enrollment
96
Locations
1
Primary Endpoint
change in IIEF score

Overview

Brief Summary

Objective: To compare the effectiveness of anti-reflux ureteral stents on improving erectile function and quality of life of patients with ureteral stents.

Methods and Populations: A total of 100 male patients who required ureteral stent placement after ureteroscopic lithotripsy were randomly assigned to two groups: those in Group T (n=50) received a standard double-J-stent, while those in Group A (n=50) underwent implantation with anti-reflux ureteral stent. Follow up for 8 weeks after surgery, including reproductive hormones and inflammation marks, Beck's depression scale, IIEF and statistics on the frequency of symptoms such as hematuria.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to 50 Years (Adult)
Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  • male sexually active patients with unilateral ureteral calculi who underwent ureteroscopy with laser lithotripsy and needed post-procedure stent

Exclusion Criteria

  • Patients were excluded if they included the following criteria: (1) age under 18 or over 50 years, (2) history of previous ureteral stenting, (3) bilateral stents, (4) moderate or severe ureteral stricture need long-term stenting (on regular exchange), (5) bladder pathology and overactive bladder, (6) symptomatic benign prostatic hyperplasia, (7) moderate or severe urinary tract infection, (8) moderate or severe cardiovascular disease, hepatic dysfunction and diabetes, (9) previous use of selective alpha-1-blocker and/or antimuscarinic agent, (10) pre-op IIEF-5 ≤ 21.

Arms & Interventions

Group A

Experimental

anti-reflux ureteral stent(INNOVEX, Shanghai, China)

Intervention: Routine laser lithotripsy (Procedure)

Group-T

Active Comparator

standard double-J-stent

Intervention: Routine laser lithotripsy (Procedure)

Outcomes

Primary Outcomes

change in IIEF score

Time Frame: Patients were followed up postoperatively according to a bi-weekly schedule, with clinical assessments at 2, 4, 6, and 8 weeks

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Rong Wang
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Rong Wang

Chief Physician

Zhangjiagang First People's Hospital

Study Sites (1)

Loading locations...

Similar Trials